No-No’s in Drug Safety

/ Aug 13, 2019

An overview covering a number of things to avoid doing when it comes to drug safety.

Read More

Different Regulatory Actions from Different Agencies

/ Jun 27, 2019

Bart Cobert explores the potential reasons for the differing regulatory actions from the different agencies.

Read More

Contributions of Nurses in Pharmacovigilance and Drug Safety

/ Jun 24, 2019

Dr. Adele Mueller explores the strong patient safety and advocacy responsibility of nurses who work in the pharmaceutical industry.

Read More

Reporting and Not Reporting Data

/ Jun 03, 2019

Bart Cobert discusses the importance of clinical safety reporting. Not only is this a legal responsibility but also an ethical one.

Read More

Medical Marijuana and Drug Safety

/ May 07, 2019

Bart Cobert addresses the use of marijuana for medical purposes and the implications for Drug Safety.

Read More

Signal Detection and Signal Management

/ Mar 27, 2019

Dr. W. Mark Riddle, M.D explores signal detection and signal management in Pharmacovigilance.

Read More

Guide to Causality Assessment

/ Mar 20, 2019

What information should be examined in the study and work up of ADRs to determine whether the reaction is likely due to the drug or not.

Read More

UK and EMA Inspections Update 2019

/ Mar 05, 2019

Bart Cobert reviews the changes and updates happening with UK and EMA inspections.

Read More

Safety Reporting: Why We Do What We Do

/ Feb 07, 2019

We participate in safety reporting not only because it is required by law, but because we are HCPs whose first duty is always to protect the patient.

Read More

Brexit Update (again)

/ Jan 28, 2019

An update on the status of Brexit and the EMA move to Amsterdam.

Read More

Blog Signup